Ross Ian L, Llahana Sofia, Anderson Michelle M, Demeke Belene, Minnie Elouise M, Wass John A H, Henry Michelle
Department of Medicine, University of Cape Town, Cape Town, South Africa.
School of Health and Medical Sciences, City St George's, University of London, London, UK.
Clin Endocrinol (Oxf). 2025 Nov;103(5):659-668. doi: 10.1111/cen.70006. Epub 2025 Jul 22.
Adrenal crisis is a potentially fatal complication of primary adrenal insufficiency (PAI) and the leading cause of death in this population. Knowledge and its application are crucial to prevention. This study aimed to assess knowledge of glucocorticoid stress dosing and adrenal crisis prevention among individuals with PAI in South Africa (SA) and the United Kingdom (UK).
Cross-sectional study comprising a researcher-administered telephone survey in SA and an online questionnaire in the UK.
A total of 286 individuals with PAI on glucocorticoid replacement therapy: 47 from SA and 239 from the UK.
The survey included questions on knowledge of glucocorticoid adjustment during intercurrent illness or stress, vulnerability (SA cohort only), and factors precipitating adrenal crises (UK cohort only).
Knowledge levels were suboptimal across both cohorts, with 72% answering correctly for infection, 54% vomiting, 52% fever, and 40% emotional stress. The UK cohort demonstrated significantly better knowledge (mean 49% correct, SD = 24.7) than the SA cohort (mean 34%, SD = 30.7; p < 0.001). Nearly a third of participants reported at least one adrenal crisis in the past year. Prior adrenal crisis experience correlated with higher knowledge scores (p = 0.049). Vulnerability scores correlated positively with adrenal crisis frequency in the SA cohort (r = 0.382; p = 0.008).
This is the first study to compare knowledge of adrenal crisis prevention in individuals with PAI across two countries with distinct healthcare services, highlighting significant knowledge gaps in both cohorts, particularly in the SA cohort. Targeted education and support group engagement are needed to address knowledge gaps and reduce adrenal crisis incidence.
肾上腺危象是原发性肾上腺皮质功能减退症(PAI)的一种潜在致命并发症,也是该人群的主要死因。知识及其应用对预防至关重要。本研究旨在评估南非(SA)和英国(UK)PAI患者对糖皮质激素应激剂量及肾上腺危象预防的知识。
横断面研究,在南非进行由研究人员实施的电话调查,在英国进行在线问卷调查。
共有286例接受糖皮质激素替代治疗的PAI患者,其中47例来自南非,239例来自英国。
调查包括关于在并发疾病或应激期间糖皮质激素调整的知识、易感性(仅南非队列)以及引发肾上腺危象的因素(仅英国队列)的问题。
两个队列的知识水平均不理想,对于感染,72%回答正确;呕吐,54%;发热,52%;情绪应激,40%。英国队列的知识水平(平均正确回答率49%,标准差=24.7)显著高于南非队列(平均34%,标准差=30.7;p<0.001)。近三分之一的参与者报告在过去一年中至少发生过一次肾上腺危象。既往肾上腺危象经历与较高的知识得分相关(p=0.049)。在南非队列中,易感性得分与肾上腺危象发生频率呈正相关(r=0.382;p=0.008)。
这是第一项比较两个拥有不同医疗服务的国家中PAI患者肾上腺危象预防知识的研究,突出了两个队列中存在的显著知识差距,尤其是南非队列。需要有针对性的教育和支持小组参与来弥补知识差距并降低肾上腺危象的发生率。